Cases 11 - 20 of 81
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 2:2023cv01150
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GW Research Limited v. InvaGen Pharmaceuticals, Inc. et al
as 1:2023cv00256
Plaintiff:
GW RESEARCH LIMITED
Defendant:
InvaGen Pharmaceuticals, Inc., CIPLA LTD., CIPLA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FENNEC PHARMACEUTICALS, INC. et al v. CIPLA LIMITED, et al.
as 2:2023cv00123
Plaintiff:
FENNEC PHARMACEUTICALS, INC. and OREGON HEALTH AND SCIENCE UNIVERSITY
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv00018
Plaintiff:
GW RESEARCH LIMITED
Defendant:
TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED et al v. ELI LILLY AND COMPANY
as 1:2022cv01130
Plaintiff:
Orbicular Pharmaceutical Technologies Private Limited and CIPLA USA, INC.
Defendant:
ELI LILLY AND COMPANY
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 3:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 2:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Counter Claimant:
CIPLA LIMITED
Defendant:
CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cipla USA, Inc. v. Ipsen Biopharmaceuticals, Inc.
as 1:2022cv00552
Plaintiff:
Cipla USA, Inc.
Defendant:
Ipsen Biopharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
